| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥395.4B | ¥399.2B | -1.0% |
| Operating Income | ¥14.7B | ¥14.7B | +0.0% |
| Ordinary Income | ¥13.8B | ¥14.9B | -7.5% |
| Net Income | ¥9.4B | ¥13.0B | -26.9% |
| ROE | 4.2% | 6.1% | - |
FY2026 Q3 results: Revenue ¥395.4B (YoY -1.0%), Operating Income ¥14.7B (YoY +0.0%), Ordinary Income ¥13.8B (YoY -7.5%), Net Income ¥9.4B (YoY -26.9%). The company maintained operating income at prior year levels despite a slight revenue decline, but net income decreased substantially due to increased financial costs and tax burden. Total assets expanded to ¥710.5B from ¥678.6B, while equity increased to ¥222.9B from ¥210.8B. Operating margin of 3.7% and net profit margin of 2.4% indicate compressed profitability requiring structural improvement. The company maintains full-year guidance of ¥54.0B revenue, ¥1.95B operating income, and ¥1.15B net income with annual dividend forecast of ¥22 per share.
[Profitability] ROE of 4.2% reflects challenging profit generation, composed of net profit margin 2.4%, asset turnover 0.556, and financial leverage 3.19x. Operating margin of 3.7% indicates operational efficiency challenges, while EBIT margin falls below typical chemical manufacturing benchmarks. Gross profit margin of 15.8% suggests limited pricing power or unfavorable product mix. Interest coverage ratio of 4.67x provides adequate but not robust coverage of interest expenses of ¥0.31B. [Cash Quality] Cash and deposits position supports operations, with working capital comprising significant receivables of ¥14.1B and inventory of ¥16.4B. Short-term debt coverage measured by quick ratio of 80.6% indicates tighter liquidity conditions. [Investment Efficiency] Asset turnover of 0.556 reflects capital-intensive operations with property, plant and equipment of ¥25.7B and construction in progress of ¥2.67B indicating ongoing capital investments. Working capital efficiency shows room for improvement with extended operating cycles. [Financial Health] Equity ratio of 31.4% (equity ¥222.9B against total assets ¥710.5B), current ratio of 143.0%, debt-to-equity ratio of 2.19 indicating elevated leverage. Total interest-bearing debt of ¥25.5B comprises short-term borrowings of ¥11.1B and long-term debt of ¥14.4B, with short-term debt representing 43.4% of total liabilities requiring refinancing attention.
Total assets increased ¥31.9B YoY to ¥710.5B, with cash position changes reflecting business expansion and capital deployment. Working capital composition shows accounts receivable of ¥14.1B and inventory of ¥16.4B, representing substantial operating capital tied up in the business cycle. Accounts payable and accrued expenses provide ¥13.0B in supplier credit, contributing to working capital financing. The increase in construction in progress to ¥2.67B signals ongoing capital expenditure for facility expansion or modernization. Interest-bearing debt structure with ¥11.1B in short-term borrowings requires active refinancing management, while long-term debt of ¥14.4B provides more stable funding. Equity growth of ¥12.1B YoY to ¥222.9B reflects retained earnings accumulation supporting capital base expansion. The company's liquidity position with current ratio of 143.0% provides adequate coverage of current liabilities of ¥30.8B, though quick ratio of 80.6% indicates reliance on inventory conversion for near-term obligations. Interest expense of ¥0.31B against operating income of ¥1.47B demonstrates financial cost impact on profitability, with debt servicing consuming approximately 21% of operating income.
Ordinary income of ¥13.8B versus operating income of ¥14.7B shows non-operating net deduction of approximately ¥0.9B, primarily driven by financial costs. Non-operating income includes dividend income of ¥0.14B and foreign exchange gains of ¥0.10B as positive contributors, while interest expenses of ¥0.31B represent the primary deduction. The difference between ordinary income and operating income represents 0.2% of revenue, indicating that core operating performance drives earnings with limited contribution from non-operating activities. The decline in ordinary income of 7.5% YoY despite flat operating income reflects increased financial burden, suggesting elevated borrowing costs or higher debt levels. Net income of ¥9.4B compared to ordinary income of ¥13.8B indicates tax and other adjustments of ¥4.4B, representing an effective tax burden of approximately 32%. The substantial 26.9% decline in net income YoY from ¥13.0B demonstrates earnings quality pressure from both non-operating costs and tax effects. Operating activities generate the primary earnings base with limited reliance on one-time gains, though the compressed margin structure indicates vulnerability to volume or cost fluctuations. Non-operating income composition remains relatively stable with recurring items such as interest and dividend income forming the core, while foreign exchange effects introduce some earnings volatility.
Profitability compression with gross margin of 15.8% and EBIT margin of 3.7% creates vulnerability to volume declines or cost increases, requiring urgent product mix optimization or cost structure improvement. Extended working capital cycle with inventory of ¥16.4B and receivables of ¥14.1B against quarterly revenue of ¥39.5B indicates approximately 152 days of combined inventory and receivables exposure, straining cash generation and increasing obsolescence and credit risks. High financial leverage with debt-to-equity ratio of 2.19 and short-term debt representing 43.4% of total debt creates refinancing risk and interest rate sensitivity, particularly as interest expenses of ¥0.31B quarterly already consume 21% of operating income, limiting flexibility for margin deterioration or rate increases.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin 3.7% significantly underperforms industry median of 8.3% (IQR: 4.8%-12.6%), ranking in lower quartile. Net profit margin of 2.4% falls below industry median of 6.3% (IQR: 3.2%-9.0%), indicating structural profitability challenges. ROE of 4.2% underperforms industry median of 5.0% (IQR: 2.9%-8.1%), though remains within interquartile range. ROA of 1.3% falls below industry median of 3.3% (IQR: 1.8%-5.2%), reflecting compressed returns on asset base.
Financial Health: Equity ratio of 31.4% substantially below industry median of 63.8% (IQR: 49.5%-74.7%), indicating elevated financial risk. Current ratio of 143.0% significantly below industry median of 284% (IQR: 210%-381%), though adequate for operational needs. Financial leverage of 3.19x exceeds industry median of 1.53x (IQR: 1.31-1.85), confirming above-average debt dependency.
Efficiency: Asset turnover of 0.556 aligns with industry median of 0.58 (IQR: 0.42-0.66), indicating comparable asset utilization efficiency. Working capital management with extended operating cycle requires attention relative to typical manufacturing cycles. Revenue decline of 1.0% underperforms industry median growth of 2.7% (IQR: -1.9%-7.9%), though remains within normal distribution.
※ Industry: Manufacturing (98 companies), Comparison: 2025-Q3 period benchmarks, Source: Proprietary analysis
Margin recovery imperative: Operating margin of 3.7% versus industry median of 8.3% represents a 4.6 percentage point gap that, if closed through product mix optimization or operational efficiency gains, would increase operating income by approximately ¥1.8B annually on current revenue base, fundamentally transforming profitability profile and supporting current valuation multiples.
Capital structure rebalancing opportunity: Debt-to-equity ratio of 2.19 versus industry median of 0.67 (implied from equity ratio differential) combined with short-term debt concentration of 43.4% suggests potential for refinancing toward longer-term structure, which could reduce rollover risk and potentially lower effective interest costs that currently consume 21% of operating income.
Working capital efficiency gains: Substantial inventory of ¥16.4B and receivables of ¥14.1B against quarterly revenue of ¥39.5B indicate potential for cash generation through cycle time reduction, with industry-typical improvements potentially releasing ¥3-5B in operating cash flow to support debt reduction or capital allocation without external financing.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.